Results 71 to 80 of about 26,947 (190)
REACTOGENICITY OF ACELLULAR PERTUSSIS VACCINE AND THE POSSIBILITY OF ITS USE IN ELDER CHILDREN
As is know, in the past few years, the incidence of pertussis has increased again. The article reveals the reasons of this phenomenon and the possible solutions for this problem.
M.G. Galitskaya +4 more
doaj +2 more sources
Immunological and Clinical Benefits of Maternal Immunization Against Pertussis: A Systematic Review
Infants are vulnerable to pertussis infection particularly before initiation of pertussis vaccination. Maternal pertussis vaccination during pregnancy has been introduced in a number of countries in order to confer on young infants indirect protection ...
Charlotte Switzer +2 more
doaj +1 more source
Immunologic profiling of the infant immune response to whole-cell and acellular pertussis vaccines
Despite robust antibody responses, immunity induced by acellular pertussis vaccine (DTaP) wanes over time and risk of pertussis seems to be lower in children who receive whole-cell vaccine (DTP) as their first dose.
C. Buddy Creech +15 more
doaj +1 more source
Pertussis has been resurgent in many countries worldwide despite good vaccine coverage. One hypothesis for this resurgence is that the current acellular pertussis (aP) vaccines, used in most developed countries, induce short-term protection, and do not ...
Alexa Dierig +10 more
doaj +1 more source
Pregnancy represents a high information need state, where uncertainty around medical intervention is common. As such, the pertussis vaccination given during pregnancy presents a unique opportunity to study the interaction between vaccine attitudes and ...
Richard M. Clarke +2 more
doaj +1 more source
Pertussis vaccination in newborns
Bordetella pertussis remains in fifth place among the leading etiologies of vaccine-preventable deaths in children around the world. The impact of this disease is considerable in North America, Latin America, Europe and other parts of the world. Therefore, new vaccination strategies have been recommended in the last decade, predominantly to protect ...
openaire +2 more sources
Introduction Whooping cough, also known as pertussis, remains a significant challenge as a vaccine-preventable disease worldwide. Since the switch from the whole-cell Pertussis (wP) vaccine to the acellular Pertussis vaccine (aP), cases of whooping cough
A-Reum Kim +2 more
doaj +1 more source
Pertussis Vaccination and Pregnancy [PDF]
Leuridan, E. +3 more
openaire +3 more sources
Innovative adjuvant strategies for next-generation pertussis vaccines
The acellular pertussis (aP) vaccine has increasingly replaced the whole-cell pertussis (wP) vaccine due to its superior safety profile. However, the aP vaccine is less effective at preventing infection and transmission of Bordetella pertussis ...
Ge Yu +10 more
doaj +1 more source
Pertussis is a highly contagious bacterial disease of the respiratory tract that can be prevented by vaccination. Before the COVID-19 pandemic, the vaccine coverage rate for the third dose of a DPT-containing vaccine was 86%, with large disparities among
Lucia F. Bricks +2 more
doaj +1 more source

